Pillstats
Rx only · Solution · Intramuscular

Glycopyrrolate

Glycopyrrolate

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US4 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCD11AA01
RxCUI (US)1546438
US makers1 labelers
Packages4
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.435$0.870$1.31$1.74Aug 2025May 2026Jul 2026
$1.394
Latest avg · Jul 22, 2026
-8%
Since Aug 20, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

701412112822025 Q12025 Q22025 Q32025 Q42026 Q1
220
Rx · 2026 Q1
384
Units dispensed
+450%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Somerset Therapeutics, LLCunknown4SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.